O-1966a synthetic, CB2 agonist

 

Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury.       (full – 2011)                               http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235339/

 

Acute effects of a selective cannabinoid-2 receptor agonist on neuroinflammation in a murine model of traumatic brain injury                                                                  (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/21332427/abstract/Acute_effects_of_a_selective_c annabinoid_2_receptor_agonist_on_neuroinflammation_in_a_murine_model_of_traumatic_brain_injury_

 

Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions.                                                              (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22442067

 

A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury.                                                                           (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22903455

 

O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms.                                               (abst – 2012)    http://www.ncbi.nlm.nih.gov/pubmed/22965195

Share a link for